======= RPS13 =======
== Gene Information ==
* **Official Symbol**: RPS13
* **Official Name**: ribosomal protein S13
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6207|6207]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P62277|P62277]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=RPS13&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RPS13|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/180476|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: N/A
|Ribosomal S13 N|
|Ribosomal S15|
|small ribosomal subunit rRNA binding|
|negative regulation of RNA splicing|
|mRNA 5-UTR binding|
|ribosome|
|cytosolic small ribosomal subunit|
|SRP-dependent cotranslational protein targeting to membrane|
|cotranslational protein targeting to membrane|
|protein targeting to ER|
|establishment of protein localization to endoplasmic reticulum|
|viral transcription|
|nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|
|viral gene expression|
|protein localization to endoplasmic reticulum|
|regulation of RNA splicing|
|translational initiation|
|protein targeting to membrane|
|mRNA binding|
|structural constituent of ribosome|
|nuclear-transcribed mRNA catabolic process|
|mRNA catabolic process|
|RNA catabolic process|
|postsynaptic density|
|establishment of protein localization to membrane|
|protein targeting|
|nucleobase-containing compound catabolic process|
|translation|
|peptide biosynthetic process|
|focal adhesion|
|establishment of protein localization to organelle|
|heterocycle catabolic process|
|cellular nitrogen compound catabolic process|
|aromatic compound catabolic process|
|organic cyclic compound catabolic process|
|protein localization to membrane|
|amide biosynthetic process|
|peptide metabolic process|
|mRNA metabolic process|
|viral process|
|protein localization to organelle|
|symbiotic process|
|cellular amide metabolic process|
|interspecies interaction between organisms|
|nucleolus|
|cellular macromolecule catabolic process|
|intracellular protein transport|
|macromolecule catabolic process|
|negative regulation of RNA metabolic process|
|RNA binding|
|organonitrogen compound biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|protein transport|
|intracellular transport|
|peptide transport|
|amide transport|
|cellular protein localization|
|cellular macromolecule localization|
|establishment of protein localization|
|cellular nitrogen compound biosynthetic process|
|RNA metabolic process|
|cellular macromolecule biosynthetic process|
|negative regulation of gene expression|
|macromolecule biosynthetic process|
|organic substance catabolic process|
|cellular catabolic process|
|establishment of localization in cell|
|nitrogen compound transport|
|membrane|
|gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|-2.28|
|[[:results:exp211|AICAR 240μM R05 exp211]]|-2.27|
|[[:results:exp59|UMK57 1μM R01 exp59]]|-2.11|
|[[:results:exp80|RO-3307 4.7μM R02 exp80]]|-1.95|
|[[:results:exp435|JQ1 0.8μM R08 exp435]]|-1.94|
|[[:results:exp306|Rapamycin 2μM R07 exp306]]|-1.83|
|[[:results:exp502|Milciclib 2μM R08 exp502]]|-1.77|
|[[:results:exp96|BI-2536 0.02μM R03 exp96]]|-1.74|
|[[:results:exp209|Deguelin 0.15μM R05 exp209]]|1.71|
|[[:results:exp362|GSK-J4 1μM R07 exp362]]|1.73|
|[[:results:exp425|Beta-Estradiol 0.55μM R07 exp425]]|1.74|
|[[:results:exp473|Cincreasin 100μM R08 exp473]]|1.85|
|[[:results:exp14|Cycloheximide 0.02μM R00 exp14]]|1.86|
|[[:results:exp239|PFI-2 4μM R05 exp239]]|2.16|
|[[:results:exp227|Cryptotanshinone 12μM R05 exp227]]|2.4|
|[[:results:exp422|Wiskostatin 3μM R07 exp422]]|2.95|
|[[:results:exp16|DABN 2μM R00 exp16]]|3.04|
^Gene^Correlation^
|[[:human genes:r:rrm1|RRM1]]|0.462|
Global Fraction of Cell Lines Where Essential: 736/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|1/1|
|909776.0|1/1|
|bile duct|28/28|
|blood|28/28|
|bone|26/26|
|breast|33/33|
|central nervous system|56/56|
|cervix|4/4|
|colorectal|16/17|
|esophagus|13/13|
|fibroblast|1/1|
|gastric|16/16|
|kidney|21/21|
|liver|20/20|
|lung|75/75|
|lymphocyte|16/16|
|ovary|26/26|
|pancreas|24/24|
|peripheral nervous system|16/16|
|plasma cell|15/15|
|prostate|1/1|
|skin|24/24|
|soft tissue|9/9|
|thyroid|2/2|
|upper aerodigestive|22/22|
|urinary tract|29/29|
|uterus|5/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 827
* **Expression level (log2 read counts)**: 8.32
{{:chemogenomics:nalm6 dist.png?nolink |}}